Results 181 to 190 of about 747,986 (295)

Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons, Nuria Guillen, Jordi Sarto, Neus Falgàs, Sergi Borrego‐Écija, Diana Esteller‐Gauxax, Magda Castellví, Adrià Tort‐Merino, Agnès Pérez‐Millan, Anna Antonell, Josep M. Augè Fradera, Gerard Piñol, Iolanda Riba, Anna Carnes‐Vendrell, Marta Cullell, Maria Teresa Osuna, Lorena Bajo, Teresa Romero, Eva Bonjoch, Joan Bello, Susana Fernández, Marta Balagué, Isabel Gómez‐Ruiz, Anuncia Boltes, Claustre Pont, Raquel Cuevas, Sara Carrillo, Laura Iglesias, Teresa Maria Casadevall Codina, Lorena Grau Guinea, Fernando Jose Espada, Raquel Sánchez‐Valle, Mircea Balasa, Albert Lladó   +33 more
wiley   +1 more source

Industrial robots reduce carbon emissions in manufacturing through global value chains. [PDF]

Sci Rep
Zhang Y, Zhu J, Wang S.
europepmc   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Global value chains and upgrading [PDF]

, 2015
Magasházi, Anikó, Szalavetz, Andrea, Éltető, Andrea   +2 more
core   +2 more sources

Industry-level estimates of export quality accounting for global value chains. [PDF]

Sci Data
Wacker KM, Ye X, Tusha D, Celani A.
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Negotiating the ethical terrain in global value chains on the road towards the SDGs. [PDF]

Asian Bus Manag
Sinkovics N, Hoque SF, Sinkovics RR, Gunaratne D.   +3 more
europepmc   +1 more source

Demand and supply exposure through global value chains: Euro-Mediterranean countries during COVID. [PDF]

World Econ, 2022
Ayadi R, Giovannetti G, Marvasi E, Vannelli G, Zaki C.   +4 more
europepmc   +1 more source

International business and global value chains

, 2019
The purpose of this chapter is to provide GVC scholars with an overview of the six main re-search paradigms on the study of the multinational enterprise within international business research. The chapter furthermore offers a number of suggestions on how each theoretical perspective can benefit the GVC research agenda.
Sinkovics, Noemi, Sinkovics, Rudolf R.
openaire   +1 more source